CAMP4 THERAPEUTICS
CAMP4 is focused on addressing the fundamental cause of disease by controlling the output of genes central to disease. By taking advantage of the gene circuitry code, CAMP4 is able to control gene production through signaling pathways the cell is already utilizing to regulate gene expression. Their predictions enables CAMP4 to have a rapid start to disease treatment, significantly reducing the time and risk to bring new medicines to patients.
CAMP4 THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.camp4tx.com
Total Employee:
11+
Status:
Active
Contact:
617-651-8867
Email Addresses:
[email protected]
Total Funding:
190 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Global Site Tag Euro
Similar Organizations
Sagimet Biosciences
Sagimet Biosciences is a biotechnology company that focuses on developing novel therapeutics to treat important diseases.
Amylon Therapeutics
Amylon Therapeutics is a biotechnology company that uses RNA Modulation Technology to target rare genetic disorders.
Amytrx Therapeutics
Amytrx Therapeutics is a biopharmaceutical company that advances the next generation of new anti-inflammatory peptide therapies.
Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
BAMF Health
BAMF Health is a biotechnology company that designs, develops, and builds cyclotron-equipped radiopharmacies and clinics.
Casma Therapeutics
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
CB Therapeutics
CB Therapeutics is a biotech company that specializes in the biosynthetic production of cannabinoids from sugar.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
DeepBiome Therapeutics
DeepBiome Therapeutics is an operator of a biotechnology company intended to develop a new drug discovery platform.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Gameto
Gameto is a biotechnology firm focused on female reproductive fertility biotech.
Iksuda Therapeutics
Iksuda Therapeutics is a biotechnology company specializing in the development of next generation biotherapeutics
Nerio Therapeutics
Nerio Therapeutics is a biotechnology company focused on the life sciences sector.
Nirrin Technologies
NIRRIN Analytics is a biotechnology company that develops real-time non-destructive bioprocess monitoring systems.
Novome Biotechnologies
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.
Parthenon Therapeutics
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Potenza Therapeutics
Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
SIWA Therapeutics
SIWA Therapeutics is a biotechnology company that has a monoclonal antibody that targets and destroys senescent cells.
TreeFrog Therapeutics
TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.
Ventyx Biosciences
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
Vesigen Therapeutics
Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Kraft Group
The Kraft Group investment in Series B - CAMP4 Therapeutics
Enavate Sciences
Enavate Sciences investment in Series B - CAMP4 Therapeutics
Andreessen Horowitz
Andreessen Horowitz investment in Series B - CAMP4 Therapeutics
Gaingels
Gaingels investment in Series B - CAMP4 Therapeutics
Polaris Partners
Polaris Partners investment in Series B - CAMP4 Therapeutics
Northpond Ventures
Northpond Ventures investment in Series B - CAMP4 Therapeutics
5AM Ventures
5AM Ventures investment in Series B - CAMP4 Therapeutics
Polaris Partners
Polaris Partners investment in Series A - CAMP4 Therapeutics
The Kraft Group
The Kraft Group investment in Series A - CAMP4 Therapeutics
5AM Ventures
5AM Ventures investment in Series A - CAMP4 Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-19 | CAMP4 Therapeutics Promotes Kelly Gold to Chief Financial Officer |
Official Site Inspections
http://www.camp4tx.com Semrush global rank: 3.87 M Semrush visits lastest month: 3.35 K
- Host name: 151.101.2.159
- IP address: 151.101.2.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CAMP4 Therapeutics"
Leadership - CAMP4
Nov 21, 2024 Director, Stem Cell Program, Boston Children’s Hospital; Grousbeck Professor of Pediatrics, Harvard Medical School; Investigator, Howard Hughes Medical InstituteSee details»
Why CAMP4? • CAMP4 - camp4tx.com
Nov 21, 2024 At CAMP4, we are pioneering a novel approach to programmable ASO therapeutics. Our RAP platform’s proprietary insights enable us to rapidly discover and …See details»
CAMP4 Therapeutics - Crunchbase Company Profile
Organization. CAMP4 Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. CAMP4 Therapeutics is a biotechnology company that uses RNA to restore …See details»
CAMP4 Therapeutics - LinkedIn
CAMP4 Therapeutics Biotechnology Research Cambridge, Massachusetts 6,643 followers Pioneering a new approach to programmable therapeutics to help patients reach new heights.See details»
CAMP4 Raises $45 Million to Usher in a New Era of …
Jun 15, 2021 Learn more about us at www.CAMP4tx.com and follow us @CAMP4tx. Contacts. Lindy Devereux Scient PR [email protected] 646-515-5730 Release Summary.See details»
About Our Name • CAMP4 - camp4tx.com
Nov 21, 2024 CAMP4 is the final camp before a climber’s final ascent to the summit of Mt. Everest. CAMP4 is also a sacred climbing haven in Yosemite where the greatest climbers …See details»
CAMP4 Reports Third Quarter 2024 Financial Results
Nov 21, 2024 Learn more about us at www.CAMP4tx.com and follow us on LinkedIn and X. Forward-Looking Statements This press release contains forward-looking statements which …See details»
CAMP4 Therapeutics Expands Leadership and Board of Directors
Jul 13, 2021 Prior to joining CAMP4, Ms. Gold held various roles in corporate finance and business planning at Biogen, where she provided financial leadership for the company’s late …See details»
CAMP4 Therapeutics Expands Leadership and Board of Directors
Jul 13, 2021 While there, Ms. Gates played a pivotal role in contributing to massive growth and global expansion of the organization, including several acquisitions, and talent driven initiatives …See details»
CAMP4 Therapeutics Expands Leadership and Board of Directors
Thadhani’s experience leading a renowned research organization and his prior therapeutic research focus will be highly valuable to our discovery and development efforts, particularly as …See details»
CAMP4 Secures $100 Million Series B Financing to ... - Enavate …
Jul 20, 2022 Learn more about us at www.CAMP4tx.com and follow us @CAMP4tx. About Enavate Sciences Enavate Sciences is a platform created by Patient Square Capital dedicated …See details»
CAMP4 Therapeutics - Overview, News & Similar companies
Oct 9, 2022 CAMP4 Therapeutics contact info: Phone number: (617) 651-8867 Website: www.camp4tx.com What does CAMP4 Therapeutics do? At CAMP4 Therapeutics, we are …See details»
CAMP4 Announces Collaboration to Discover Novel Targets to …
Jan 10, 2020 Our vision is to create a world where a treatment for every disease is possible. Learn more about us at www.camp4tx.com. Contacts. Media: Liz Melone [email protected] …See details»
CAMP4 Reports Third Quarter 2024 Financial Results | Nasdaq
Nov 21, 2024 Learn more about us at www.CAMP4tx.com and follow us on LinkedIn and ... the Company’s ability to grow the Company’s organization, ...See details»
CAMP4 Secures $100 Million Series B Financing to Accelerate …
Jul 20, 2022 Enavate Sciences, a portfolio company created by Patient Square Capital, led the round. Additional investors in the Series B financing include a large national managed care …See details»
CAMP4 Secures $100 Million Series B Financing to Accelerate …
Jul 20, 2022 Additional investors in the Series B financing include a large national managed care organization and the Gaingels, an LGBTQIA+/Allies investment syndicate supporting diversity …See details»
CAMP4 Therapeutics Promotes Kelly Gold to Chief Financial Officer
Apr 19, 2022 She has extensive knowledge of CAMP4’s financial organization and experience leading business development, operations, accounting, investor relations and corporate …See details»
Camp4 Raises $100 Million in Series B - The SaaS News
Jul 21, 2022 The round was led by Enavate Sciences, a portfolio company created by Patient Square Capital, with participation from a large national managed care organization and the …See details»
CAMP4 Raises $45 Million to Usher in a New Era of Programmable ...
Learn more about us at www.CAMP4tx.com and follow us @CAMP4tx. Contact: Lindy Devereux Scient PR [email protected] 646-515-5730 . Author: Lindy Devereux Created Date:See details»